MedPath

Impact of a Low Carbohydrate Breakfast on Glucose Control in Type 2 Diabetes

Not Applicable
Completed
Conditions
Type2 Diabetes
Interventions
Behavioral: Low Carbohydrate Breakfast
Behavioral: Guidelines Breakfast
Registration Number
NCT02982330
Lead Sponsor
University of British Columbia
Brief Summary

Large glucose excursions at breakfast are prevalent in type 2 diabetes and can contribute to sustained hyperglycaemia across the day. Lowering consumption of dietary carbohydrate is known to reduce post-meal glucose excursions but it is unknown whether lowering the carbohydrate at breakfast only will impact subsequent post meal glucose excursions throughout the day. The aim of this study is to examine, under free living conditions and using typical dietary patterns, whether eating a breakfast low in carbohydrate can lower daily post-meal glycemia when compared to consuming a low-fat breakfast (per the current diabetes guidelines).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria
  • Physician-diagnosed Type 2 Diabetes (>6 months)
Read More
Exclusion Criteria
  • Exogenous Insulin
  • A1c > 9%
  • Cardiovascular, liver, or renal other disease
  • Breakfast and meal skippers
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Low Carbohydrate BreakfastGuidelines BreakfastBreakfast composition containing \<10% carbohydrate, 75% fat, 15% protein Matched calories
Low Carbohydrate BreakfastLow Carbohydrate BreakfastBreakfast composition containing \<10% carbohydrate, 75% fat, 15% protein Matched calories
Guidelines BreakfastLow Carbohydrate BreakfastBreakfast composition containing 55% carbohydrate, 30% fat, 15% protein Matched calories
Guidelines BreakfastGuidelines BreakfastBreakfast composition containing 55% carbohydrate, 30% fat, 15% protein Matched calories
Primary Outcome Measures
NameTimeMethod
Incremental area under the glucose curve (continuous glucose monitor)24 hour (one day)
Secondary Outcome Measures
NameTimeMethod
Mean Blod Glucose (continuous glucose monitor)24 hours (one day)

Trial Locations

Locations (1)

University of British Columbia, Okanagan.

🇨🇦

Kelowna, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath